Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.

Dan-Qing Lou1, Thierry Molina, Myriam Bennoun

  • 1Département GDPM, Institut Cochin, INSERM U-567, CNRS UMR 8104, Université Paris 5, 24 rue du Faubourg Saint-Jacques, 75014 Paris, France.

Cancer Letters
|September 15, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Early positron emission tomography response-adapted treatment in low-risk diffuse large B-cell lymphoma: an open-label, multicenter, randomized, noninferiority phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study.

The Lancet. Rheumatology·2025
Same author

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.

Blood advances·2025
Same author

Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials-a LYSA and GLA/ DSHNHL collaboration.

Leukemia·2024

Researchers developed a new mouse model that accurately replicates human liver cancer development. This model allows for the study of early cancer stages and the evaluation of potential new therapies for hepatocellular carcinoma.

Area of Science:

  • Hepatology
  • Oncology
  • Transgenic animal models

Background:

  • Sporadic hepatocarcinoma (liver cancer) arises in vivo.
  • Existing models may not fully recapitulate the in vivo setting for liver cancer development.

Purpose of the Study:

  • To establish a novel transgenic mouse model that mimics sporadic hepatocarcinoma.
  • To enable investigation of early preneoplastic processes in the liver.
  • To identify potential therapeutic targets for liver cancer.

Main Methods:

  • Developed a transgenic mouse model with regulatable SV40 early sequences under hepatic control (human antithrombin III gene regulatory sequences).
  • Activated oncogenic sequences using adenoviral Cre recombinase or liver-specific, tamoxifen-inducible Cre expression.

Related Experiment Videos

  • Induced hepatocellular carcinoma (HCC) through controlled oncogene activation.

    • Main Results:

    • Successfully generated a mouse model that develops hepatocellular carcinoma.
    • Demonstrated that both adenoviral and inducible Cre systems effectively activated oncogenes in the liver.
    • The model closely mimics the in vivo conditions of sporadic liver cancer.

    Conclusions:

    • The developed transgenic mouse model is a valuable tool for studying hepatocarcinogenesis.
    • This model facilitates research into the preneoplastic stages of liver cancer.
    • It offers a platform for preclinical testing of novel therapeutic strategies for HCC.